HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Henke Selected Research

Squamous Cell Carcinoma of Head and Neck

7/2015A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
10/2013Reirradiation plus EGFR inhibition in locally recurrent and unresectable head and neck cancer: final results from a single institution.
8/2013Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck.
11/2001Alteration of radiation-induced hematotoxicity by amifostine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Henke Research Topics

Disease

6Head and Neck Neoplasms (Head and Neck Cancer)
10/2013 - 09/2000
4Neoplasms (Cancer)
07/2015 - 10/2001
4Squamous Cell Carcinoma of Head and Neck
07/2015 - 11/2001
3Anemia
10/2001 - 02/2000
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2004 - 04/2001
2Hypoxia (Hypoxemia)
10/2001 - 02/2000
2Xerostomia
12/2000 - 10/2000
2Mucositis
10/2000 - 09/2000
1Disease Progression
07/2015
1Anaphylaxis (Anaphylactic Shock)
10/2013
1Margins of Excision
08/2013
1Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2013
1Hypersensitivity (Allergy)
08/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2006
1Lymphatic Metastasis
04/2006
1Neoplasm Metastasis (Metastasis)
04/2006
1Carcinoma (Carcinomatosis)
05/2004
1Circulating Neoplastic Cells
05/2001
1Dental Caries (Decay, Dental)
12/2000
1Nausea
10/2000
1Vomiting
10/2000
1Dermatitis
09/2000
1Pathologic Constriction (Stenosis)
06/2000

Drug/Important Bio-Agent (IBA)

3ErythropoietinFDA Link
05/2004 - 02/2000
2Cetuximab (Erbitux)FDA Link
10/2013 - 08/2013
2Hemoglobins (Hemoglobin)IBA
05/2004 - 09/2000
2Amifostine (Ethyol)FDA LinkGeneric
12/2000 - 10/2000
1ErbB Receptors (EGF Receptor)IBA
07/2015
1EpitopesIBA
07/2015
1Monoclonal AntibodiesIBA
07/2015
1futuximabIBA
07/2015
1Fish OilsIBA
06/2013
1Leucine (L-Leucine)FDA Link
06/2013
1Proteins (Proteins, Gene)FDA Link
06/2013
1Dinoprostone (PGE2)FDA Link
06/2013
1OligosaccharidesIBA
06/2013
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2013
1Glucose (Dextrose)FDA LinkGeneric
12/2004
1Cytostatic AgentsIBA
10/2001
1Messenger RNA (mRNA)IBA
05/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2001
1Keratin-19 (Keratin 19)IBA
05/2001
1Fluorine-18IBA
04/2001
1Nylons (Nylon)IBA
06/2000

Therapy/Procedure

8Radiotherapy
06/2013 - 09/2000
1Re-Irradiation
10/2013
1Adjuvant Chemoradiotherapy
08/2013
1Combined Modality Therapy
04/2006
1Drug Therapy (Chemotherapy)
04/2006
1Pneumonectomy (Lung Volume Reduction)
04/2006
1Therapeutics
04/2006
1Chemoradiotherapy
05/2004
1Catheters
06/2000
1Stents
06/2000